Epidemiological Survey of Cutaneous Leishmaniasis in Gonbad-e-Kavus, Northern Iran

Document Type : Original Article


1 Department of Medical Entomology and Vector Control, Health Science Research Center, Faculty of Health, Mazandaran University of Medical Sciences,

2 Department of Medical Entomology and Vector Control, Faculty of Health, Mazandaran University of Medical Sciences, Sari,

3 Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Rodentology Research Department, Faculty of Sciences, Institute of Applied Zoology, erdowsi University of Mashhad, Mashhad, Iran



Cutaneous leishmaniasis (CL) is one of the most important health problems in Iran. The aim of this study was to investigate all aspects of the epidemiology of the disease, including examination of patients, the rate and nature of the disease, and the development of different forms of disease during 2009–2018 in Gonbad-e-Kavus, Northern Iran.
Materials and Methods: 
This descriptive study was performed using epidemiological data, including demographic and clinical features collected from 5638 patients diagnosed with leishmaniasis in health centers affiliated to the Deputy of Health Center of Golestan University of Medical Sciences during 2009–2018.
A total number of 5638 individuals were diagnosed with CL over a 10-year period. Considering the population of Golestan, the incidence rate was reported as 137 per 100,000 populations. It was also revealed that most of the cases of CL (86/23%) lived in the villages and the majority of patients (21/46%) were in the age group of 1–4. In addition, most ulcers were observed in the hand (37.7%) and foot (33.1%), respectively. Most of the patients had multiple wounds on the body. The highest incidence was reported in November and the lowest in May.
The results of this study showed that the endemicity of disease in Gonbad-e-Kavus city during the 10-year study period 2009–2018 was high compared to the average incidence rate of CL in Iran. Therefore, monitoring and emphasizing disease control methods to eliminate leishmaniasis in this city are essential.


1.     Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
2.     Sharma U, Singh S. Immunobiology of leishmaniasis. Indian J Exp Biol 2009;47:412-23.
3.     Ul Bari A. Epidemiology of cutaneous leishmaniasis. JPMA 2006;16:156-62.
4.     World Health Organization. Leishmaniasis; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis. [Last accessed on 2020 Mar 2].
5.     Knapp AP, Alpern JD. Cutaneous leishmaniasis. N Engl J Med 2020;382:e2.
6.     Ghatee MA, Taylor WR, Karamian M. The geographical distribution of cutaneous leishmaniasis causative agents in Iran and its neighboring countries, a review. Front Public Health 2020;8:11.
7.     Firooz A, Mortazavi H, Khamesipour A, Ghiasi M, Abedini R, Balighi K, et al. Old world cutaneous leishmaniasis in Iran: Clinical variants and treatments. J Dermatolog Treat 2020;8:1-11.
8.     Shirzadi MR, Esfahani SB, Mohebali M, Reza M, Ershadi Y, Gharachorlo F, et al. Epidemiological status of leishmaniasis in Iran 1362-1392. Iran J Clinic Infect Dis 2016;21(73).
9.     Yaghoobi-Ershadi MR, Akhavan AA, Mohebali M. Meriones libycus and Rhombomys opimus (Rodentia: Gerbillidae) are the main reservoir hosts in a new focus of zoonotic cutaneous leishmaniasis in Iran. Trans R Soc Trop Med Hyg 1996;90:503-4
10.     Mollalo A, Alimohammadi A, Shirzadi MR, Malek MR. Geographic information system-based analysis of the spatial and spatio-temporal distribution of zoonotic cutaneous leishmaniasis in Golestan Province, north-east of Iran. Zoonoses Public Health 2015;62:18-28.
11.     Jorjani O, Mirkarimi K, Charkazi A, Shahamat YD, Mehrbakhsh Z, Bagheri A. The epidemiology of cutaneous leishmaniasis in Golestan Province, Iran: A cross-sectional study of 8-years. Parasite Epidemiol Control 2019;5:e00099.9.
12.     Sofizadeh A, Cherabin M, Mehravaran A. Cutaneous leishmaniasis inGonbad Kavoos, North of Iran (2009-11): An epidemiological study. J Gorgan Univ Med Sci 2012;14:100-6.
13.     Shirzadi MR, Esfahania SB, Mohebalia M, Ershadia MR, Gharachorlo F, Razavia MR, et al. Epidemiologicalstatus of leishmaniasisin the Islamic Republic of Iran, 1983-2012. East Mediterr Health J 2015;21:736-42.
14.     Sofizadeh A, Vatandoost H, Rassi Y, Hanafi-Bojd AA, Rafizadeh S. Spatial analyses of the relation between rodent’s active burrows and incidence of zoonotic cutaneous leishmaniasis in Golestan province, northeastern of Iran. J Arthropod Borne Dis 2016;10:569.
15.     Ghavibazou L, Hosseini-Vasoukolaei N, Akhavan AA, Jahanifard E, Yazdani-Charati J, Fazeli-Dinan M. Dispersal status of cutaneous leishmaniasis in Mazandaran province, 2009-2017. J Mazandaran Univ Med Sci 2018;28:58-70.
16.     Badirzadeh A, Mohebali M, Asadgol Z, Soong L, Zeinali M, Mokhayeri Y, et al. The burden of leishmaniasis in Iran, acquired from the global burden of disease during 1990–2010. Asian Pac J Trop Dis 2017;7:513-8.
17.     Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001;95:239-43.
18.     Moosazadeh M, Afshari M, Parsaee M, Nezammahalleh A, Abedi G, Fakhar M, et al. Clinico-epidemiological features of cutaneous leishmaniasis in Mazandaran Province, northern Iran. Clin Epidemiol Glob Health 2019;7:378-81.
19.     Talari SA, Vakili Z, Moshtaghi S. Prevalence of cutaneus leishmaniasis in Kashan, 1994-2000. FEYZ 2003;7:71-6.
20.     Khajedaluee M, Yazdanpanah MJ, Seyed Nozadi S, Fata A, Juya MR, Masoudi MH, et al. Epidemiology of cutaneous leishmaniasis in population covered by Mashhad University of Medical Sciences in 2011. Med J Mashhad Univ Med Sci 2014;57:647-54.
21.     Rassi Y, SofizadehA,Abai MR, Oshaghi MA, Rafizadeh S, Mohebail M, et al. Molecular detection of Leishmania major in the vectors and reservoir hosts of cutaneous leishmaniasis in Kalaleh District, Golestan Province, Iran. J Arthropod Borne Dis 2008 ;2:21-7.
22.     Scott P, Novais FO. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat Rev Immunol 2016;16:581-92.
23.     Yaghoobi-Ershadi MR, Akhavan AA. Entomological survey of sandflies (Diptera: Psychodidae) in a new focus of zoonotic cutaneous leishmaniosis in Iran. Acta Trop 1999;73:321-6.
24.     Hosseini-Vasoukolaei N,Idali F, KhamesipourA,Yaghoobi-Ershadi MR, Kamhawi S, Valenzuela JG, et al. Differential expression profiles of the salivary proteins SP15 and SP44 from Phlebotomus papatasi. Parasit Vectors 2016;9:357.
25.     Khoobdel M, Dehghan O, Bakhshi H, Moradi M. Control and management of vector-borne diseases in disaster conditions. Mil Med 2020;22:778-98.
26.     Ghias M, Moradpour S, Karimi S. The comparison of the effects of climatic elements in cutaneous leishmaniosis incidence in two Gilane-Gharb and Kermanshah counties, between 2006-2016. Journal of Spatial Planning 2019;9:45-60.
27.     Mokhtari H, Golmakani M. Evaluation of epidemiologic causes in cutaneousleishmanious patientsreferred to health care center of Mashhad Moghadas province from 2008 to 2013. Manage Sci 2017;7:1-13.
28.     Giraud E, Martin O, Yakob L, Rogers M. Quantifying Leishmania metacyclic promastigotes from individual sandfly bites reveals the efficiency of vector transmission. Commun Biol 2019;2:84.